Health Economical Aspects of Alzheimer Disease and its Treatment
Open Access
- 1 September 2001
- journal article
- Published by Wiley in Psychogeriatrics
- Vol. 1 (3) , 189-193
- https://doi.org/10.1111/j.1479-8301.2001.tb00047.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: A Markov modelClinical Therapeutics, 1999
- The Cost of Dementia in Denmark: The Odense StudyDementia and Geriatric Cognitive Disorders, 1999
- Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in CanadaJournal of the American Geriatrics Society, 1999
- Estimating Long Term Cost Savings from Treatment of Alzheimer??s DiseasePharmacoEconomics, 1999
- First International Pharmacoeconomic Conference on Alzheimerʼs Disease: Report and SummaryAlzheimer Disease & Associated Disorders, 1998
- Cognitive Function and the Costs of Alzheimer DiseaseArchives of Neurology, 1997
- The economic impact of tacrine in the treatment of Alzheimer's diseaseClinical Therapeutics, 1997
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's DiseaseNew England Journal of Medicine, 1997
- Long-term tacrine (Cognex) treatmentNeurology, 1996
- The US economic and social costs of Alzheimer's disease revisited.American Journal of Public Health, 1994